Cargando…
Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study
In vitro data suggest the monoclonal antibody sotrovimab may have lost inhibitory capability against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant. We aimed to provide real-life data on clinical outcomes in hospitalized patients. We retrospectively analyzed patient...
Autores principales: | Woo, Marcel S., Brehm, Thomas Theo, Fischer, Marlene, Heyer, Andreas, Wichmann, Dominic, Jordan, Sabine, Nörz, Dominik, Lütgehetmann, Marc, Addo, Marylyn M., Lohse, Ansgar W., Schmiedel, Stefan, Kluge, Stefan, Schulze zur Wiesch, Julian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927465/ https://www.ncbi.nlm.nih.gov/pubmed/36475890 http://dx.doi.org/10.1128/spectrum.04103-22 |
Ejemplares similares
-
Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
por: Brehm, Thomas Theo, et al.
Publicado: (2022) -
Management der saisonalen Influenza 2017/2018: Erfahrungen an einem deutschen Universitätsklinikum
por: Kraef, Christian, et al.
Publicado: (2019) -
Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection
por: Cords, Leon, et al.
Publicado: (2023) -
Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
por: Brehm, Thomas Theo, et al.
Publicado: (2021) -
Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients
por: Pflüger, Lisa Sophie, et al.
Publicado: (2020)